Abstract:Objectives Increasing evidences shown the important role of bone marrow-derived mesenchymal stem cells (BM-MSCs) in wound healing and vascular remodelling in vivo. However, their mechanism in the development of atherosclerosis and vessel calcify remain unclear. Objective To investigate the effects of Oxidatively Modified Low Density Lipoprotein (ox-LDL ) on proliferation and osteodiferenliation of BM-MSCs that Co-cultured with Smooth Muscle Cells with or without osteogenic inductor being then we try to explain the mechanism of how MSCs participate in atherosclerosis. Methods BM-MSCs and VSMCs were prepared from SD rats and co-cultured in a Transwell system, which allowed the diffusion of secreted factors but prevented cell contact between the two cell types. Four groups were designed according as factorial design, which were Combine group (both osteogenic inductor and ox-LDL), ox-LDL group, Osteogenic inductor group and control group. The proliferation of BM-MSCs was determined by MTT assay. The their effects on the osteogenic potential of BM-MSCs by cell morphology, real-time PCR, immunofluorescent staining, alkaline phosphatase (AKP) activity and Osteopontin (OPN) synthesis. Results 1. The growth curve showed that cells number of all four groups increased along with time. The ability of promoting cellular proliferation in ox-LDL (5 mg/L) group were showed strongest in four groups, but that of combine group were opposite at 7days, 10 days and 14 days. 2. At the cultured 7 days, 10 days, all groups express OPN mRNA and AKP and but the combine group was highest. There was interaction between the two factors (P < 0.01). 3. The result of Immunity histochemistry showed that the rate of OPN and AKP positive cells in combine group were the highest at 14 days. Conclusions Increasing evidences indicated a link between bone marrow cells and the pathogenesis of atherosclerosis. It was recognized that a higher percentage of circulating endothelial progenitor cells expressed osteocalcin in patients with coronary atherosclerosis. Widespread increased myeloid calcifying cells contribute to ectopic vascular calcification in type 2 diabetes. Furthermore, mouse model and human studies have suggested that bone marrow-derived progenitor cells may contribute to a variety of vascular pathologies including calcification, atherosclerosis and intimal hyperplasia. In view of the capacity of differentiation into osteoblast from BM-MSCs, we investigated whether BM-MSCs was involved in the process of angiosteosis in atherosclerosis when exposed to vascular injure and hyperlipemia. Thus, we mimicked the phenotype transformation of VSMC exposed to hyperlipemia to investigate the differentiation of BM-MSCs. Data reported in this study demonstrated that ox-LDL significantly promoted proliferation of BM-MSCs co-cultured with VSMC, but not osteoblast differentiation. The proproliferative role of ox-LDL was neutralised by Osteogenic inductor, but apoptosis was induced instead. We results showed that ox-LDL can promote the proliferation of BM-MSCs, and Osteogenic Inductor mediated Osteodifferentiation marker expression in BM-MSCs in vitro.

Comparison Of Transforming Growth Factor-Beta1 And Lovastatin On Differentiating Mesenchymal Stem Cells Toward Nucleus Pulposus-Like Phenotype: An In Vitro Cell Culture Study

TGF-β3 and IGF-1 Synergy Ameliorates Nucleus Pulposus Mesenchymal Stem Cell Differentiation Towards the Nucleus Pulposus Cell Type Through MAPK/ERK Signaling

Small Molecule-Based Strategy Promotes Nucleus Pulposus Specific Differentiation of Adipose-Derived Mesenchymal Stem Cells.

Roles of FGF-2 and TGF-beta/FGF-2 on differentiation of human mesenchymal stem cells towards nucleus pulposus-like phenotype.

Influence of simvastatin on the biological behavior of nucleus pulposus-derived mesenchymal stem cells

Proportion of collagen type II in the extracellular matrix promotes the differentiation of human adipose‐derived mesenchymal stem cells into nucleus pulposus cells

Different Impact by Oxidized Low Density Lipoprotein and Transforming Growth Factor-β1 on the Proliferation and Differentiation of Bone Marrow Mesenchymal Stem Cells

Influence of simvastatin on the proliferation and secretion functions of nucleus pulposus-derived mesenchymal stem cells

BMP3 Alone and Together with TGF-β Promote the Differentiation of Human Mesenchymal Stem Cells into a Nucleus Pulposus-Like Phenotype

A systematic investigation of the effects of TGF-β3 and mechanical stimulation on tenogenic differentiation of mesenchymal stromal cells in a poly(ethylene glycol)/gelatin-based hydrogel

GW24-e2290 Effects of Oxidatively Modified Low Density Lipoprotein on Proliferation and Osteodifferentiation of Mesenchymal Stem Cells That Co-Cultured with Vascular Smooth Muscle Cells

[Effects of Simvastatin Nano-Liposomes on Osteogenic Differentiation of Bone Marrow Stromal Cells].

TGF-β1 and -β3 for Mesenchymal Stem Cells Chondrogenic Differentiation on Poly (Vinyl Alcohol)-Chitosan-Poly (Ethylene Glycol) Scaffold

Differentiation of GFP-Bcl-2-engineered Mesenchymal Stem Cells Towards a Nucleus Pulposus-Like Phenotype under Hypoxia in Vitro

Growth differentiation factor 6 and transforming growth factor-beta differentially mediate mesenchymal stem cell differentiation, composition, and micromechanical properties of nucleus pulposus constructs

P108 TGF-BATE1 DOSE AND CELLULAR DENSITY-DEPENDENT EFFECT ON CHONDROGENIC DIFFERENTIATION OF HUMAN BONE MARROW STEM CELLS

Comparison of the biological effects of two kinds of homologous mesenchymal stem cells on degenera-tive nucleus pulposus cells under the condition of non-contact co-culture

Chondrogenic Differentiation of Mesenchymal Stem Cells by Transforming Growth Factor-β1 Gene transfection with Liprofectamine

Fluvastatin promotes chondrogenic differentiation of adipose-derived mesenchymal stem cells by inducing bone morphogenetic protein 2

Differential response of human bone marrow stromal cells to either TGF-β1 or rhGDF-5

Examining the effects of HMG-CoA reductase inhibitors on anabolic and catabolic signaling pathway proteins associated with degenerative disc disease